Key facts
- This page summarizes Dajun Yang's Form 4 filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).
- 12 reported transactions and 10 derivative rows are listed below.
- Accepted by SEC: 22 May 2026, 16:18.
Dajun Yang - 20 May 2026 Form 4 Insider Report for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
- Reporting relationship
- Chairman and CEO, Director
- Issuer ticker
- AAPG
- Reported as of
- 20 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 May 2026, 16:18:28 UTC
- Prior SEC filing
- 23 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /S/Thomas J. Knapp, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dajun Yang filed Form 4 for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) on 22 May 2026.
Change
- Previous filing in this sequence was filed on 23 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002059751
Primary reporting owner
Yang Dajun
- Relationship
- Chairman and CEO, Director
- Address
- C/O ASCENTAGE PHARMA GROUP INC., 700 KING FARM BLVD., SUITE 510, ROCKVILLE
- Signature
- /S/Thomas J. Knapp, as attorney-in-fact
- Signature date
- 22 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AAPG
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +95,575
- Change %
- +8.7%
- Price
- $0.000000*
- Shares after
- 1,193,569
- Date
- 21 May 2026
- Ownership
- Direct
AAPG
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +92,746
- Change %
- +30%
- Price
- $0.000000*
- Shares after
- 405,280
- Date
- 21 May 2026
- Ownership
- See Footnote (2)
- Footnotes
- F2
AAPG
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 22,054,131
- Date
- 20 May 2026
- Ownership
- See Footnote (1)
- Footnotes
- F1
AAPG
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 14,089,111
- Date
- 20 May 2026
- Ownership
- See Footnote (3)
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AAPG
transaction
Derivative
Restricted stock units
Award
- Transaction value
- Shares
- +95,575
- Change %
- Price
- $0.000000*
- Shares after
- 95,575
- Date
- 20 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 95,575
- Exercise price
- $0.000000
- Footnotes
- F4
AAPG
transaction
Derivative
Restricted stock units
Options Exercise
- Transaction value
- Shares
- -95,575
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 95,575
- Exercise price
- $0.000000
- Footnotes
- F5
AAPG
transaction
Derivative
Restricted stock units
Award
- Transaction value
- Shares
- +298,195
- Change %
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 298,195
- Exercise price
- $0.000000
- Footnotes
- F6
AAPG
transaction
Derivative
Options
Award
- Transaction value
- Shares
- +298,194
- Change %
- Price
- $0.000000*
- Shares after
- 298,194
- Date
- 20 May 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 298,194
- Exercise price
- $6.58
- Footnotes
- F7
AAPG
transaction
Derivative
Restricted stock units
Award
- Transaction value
- Shares
- +103,365
- Change %
- Price
- $0.000000*
- Shares after
- 103,365
- Date
- 20 May 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 103,365
- Exercise price
- $0.000000
- Footnotes
- F8
AAPG
transaction
Derivative
Restricted stock units
Award
- Transaction value
- Shares
- +214,999
- Change %
- Price
- $0.000000*
- Shares after
- 214,999
- Date
- 20 May 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 214,999
- Exercise price
- $0.000000
- Footnotes
- F6
AAPG
transaction
Derivative
Options
Award
- Transaction value
- Shares
- +214,988
- Change %
- Price
- $0.000000*
- Shares after
- 214,988
- Date
- 20 May 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 214,988
- Exercise price
- $6.58
- Footnotes
- F7
AAPG
transaction
Derivative
Options
Award
- Transaction value
- Shares
- +103,364
- Change %
- Price
- $0.000000*
- Shares after
- 103,364
- Date
- 20 May 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 103,364
- Exercise price
- $8.12
- Footnotes
- F9
AAPG
transaction
Derivative
Restricted stock units
Award
- Transaction value
- Shares
- +92,746
- Change %
- Price
- $0.000000*
- Shares after
- 92,746
- Date
- 20 May 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 92,746
- Exercise price
- $0.000000
- Footnotes
- F10
AAPG
transaction
Derivative
Restricted stock units
Options Exercise
- Transaction value
- Shares
- -92,746
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 21 May 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 92,746
- Exercise price
- $0.000000
- Footnotes
- F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 11 footnotes
Footnote F1
Shares held by Dajun Yang Dynasty Trust, of which the Reporting Person is the investment advisor. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Footnote F2
Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Footnote F3
Shares held by HealthQuest Pharma Limited, an entity controlled by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Footnote F4
Each restricted stock unit (the "RSUs") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date.
Footnote F5
Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.
Footnote F6
The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.
Footnote F7
The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant.
Footnote F8
The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date.
Footnote F9
The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant.
Footnote F10
The RSUs vested on 05/21/2026 and had no expiration date.
Footnote F11
Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.